http://www.isdscotland.org/ Stroke Health statistics Tue, 24 Apr 2012 01:00:00 GMT Tue, 24 Apr 2012 01:00:00 GMT http://www.isdscotland.org/rss ISD Scotland NSS.isdexternalwebsite@nhs.net (ISD Web Team) NSS.isdexternalwebsite@nhs.net (ISD Web Team) http://www.isdscotland.org/Health-Topics/Stroke/Publications/index.asp#640 Age-standardised mortality rates for CVD (for those under 75) fell from 17.2 per 100,000 population in 2009 to 15.3 per 100,000 population in 2010, a decrease of almost 11%. They have fallen by 59% over the period 1995-2010, meeting the Scottish Government target of a 50% reduction in premature stroke mortality over the period 1995-2010. The overall costs of prescriptions dispensed for cardiovascular related drugs fell sharply in 2010/11 to £167 million, a reduction of 11.4% on the previous year. This is the lowest gross ingredient cost for cardiovascular drugs observed for any year over the last decade 2001/02 to 2010/11. The annual costs reached a peak of £232 million in 2003/04. Costs often reduce as medicines become available in generic form once drug patents expire.Over the decade 2001/02 - 2010/11 the numbers of prescriptions dispensed for cardiovascular related drugs continued to rise although there has been a slight reduction (0.2%) over the last year to 24,633,819 items prescribed and dispensed in the community in 2010/11. Tue, 29 Nov 2011 09:30:00 GMT http://www.isdscotland.org/Health-Topics/Stroke/Publications/index.asp#640 http://www.isdscotland.org/Health-Topics/Stroke/Publications/index.asp#736 Age-standardised mortality rates for CVD ( cerebrovascular disease ),for those under 75, fell from 19.6 per 100,000 population in 2008 to 17.2 per 100,000 population in 2009, a decrease of 12.4%.  They have fallen by 54.4% over the period 1995-2009, meeting the Scottish Government target of a 50% reduction in premature stroke mortality over the period 1995-2010.Between 2000/01 and 2009/10 the incidence rate for CVD (total number of people diagnosed with CVD per 100,000 population, standardised by age and sex) decreased by 21.3% (from 209.8 cases per 100,000 population in 2000/01 to 165.1 cases per 100,000 population in 2009/10)The number of prescriptions for cardiovascular disease (both coronary heart disease and cerebrovascular disease) increased by 61%  in the last decade (from 15 million in 2000/01 to 25 million in 2009/10). The associated costs over the same period rose by a fifth, from £150 million to £187 million, and reached a peak of £230 million in 2004/05 before reducing to £187 million in 2009/1 Tue, 22 Feb 2011 09:30:00 GMT http://www.isdscotland.org/Health-Topics/Stroke/Publications/index.asp#736